Research explainers
Compare the claim with the study
See who was studied, what changed and what remains unknown. Each explainer includes optional study comparisons and a public evidence card you can print or share.
These are dated assessments of existing research. The assessment date is not a new study publication date. All evidence and results are free to read.
Open evidence history and your watchlist01
Multivitamin · Randomized human trial
COSMOS did not establish a reduction in total invasive cancer during its follow-up. This result does not settle every use of a multivitamin.
Assessed 2026-11-15 · Main study published 2022-03-16
02
Omega-3 · Randomized human trial
VITAL did not establish a reduction in its primary cardiovascular outcome. A positive result for prescription EPA in a different population cannot be assumed to apply to an ordinary fish-oil supplement.
Assessed 2026-11-15 · Main study published 2018-11-10
03
Glucosamine · Randomized human trial
GAIT did not establish an overall pain benefit for glucosamine hydrochloride alone. Its exploratory combination-treatment subgroup is not proof that glucosamine alone works.
Assessed 2026-11-15 · Main study published 2006-02-23
04
Magnesium · Randomized human trial
The trial found a small additional improvement in reported insomnia symptoms over four weeks. It did not establish an objective sleep benefit or superiority to other magnesium forms.
Assessed 2026-11-15 · Main study published 2025-08-30
05
Psilocybin · Mouse and cell experiments
This study cannot establish a human lifespan benefit. More treated mice survived to the study endpoint, but the experiment ended before their full lifespans were observed.
Assessed 2026-11-15 · Main study published 2025-07-08
Study comparisons explain research scope. They do not diagnose, assess personal safety or recommend treatment.